MBChB MRCP MD(Res)
Email address: firstname.lastname@example.org
Dr Chris Laing is a consultant nephrologist at the Royal Free London NHS Foundation Trust and is associate medical director for patient safety. He trained in nephrology and internal medicine in north London and undertook advanced training in critical care in the Thames region. He undertook research training at University College London under the supervision of Professor Robert Unwin, including a secondment to INSERM PARIS, achieving MD(Res) UCL.
He undertakes clinical sessions in nephrology at the Royal Free Hospital and also provides outreach services to University College London Hospital.
His clinical and research interest is acute kidney injury. During his time as clinical lead in nephrology he led the design and opening of the Royal Free acute kidney unit. This provides acute care to renal patients across north central London. He also served for three years as trust speciality training director in nephrology. He is foundational chair of the London AKI Network, the world's first clinical network for acute kidney injury, and is currently a member of the NHS England Think Kidneys programme board. He was a member of the NICE acute kidney injury guideline development group and an adviser to the NCEPOD national enquiry into AKI 'adding insult to injury'. He is clinical lead for UCL Partners Patient Safety Programme Collaborative on acute kidney injury. He co-founded the AKI Academy, the AKI frontiers conference and co-directs the UCL course on renal physiology. He is active in research in to acute kidney injury, having published widely on this topic and presenting regularly at national and international meetings.
He was renal lead for the ERICCA study - a large RCT examining the effect of ischaemic preconditioning on outcomes, including AKI, following cardiac surgery. This was published in the New England Medical Journal in October 2015.
Dr Laing is currently associate medical director for patient safety. In this role he provides senior clinical leadership on matters relating to patient safety. This includes oversight of the investigation and learning from safety incidents as well as providing clinical leadership to the trust's patient safety programme. The latter is a large cross-trust quality improvement programme aiming at reduction in avoidable harm. This is the largest cross-trust patient safety improvement programme in UCL Partners.